Follow this preprint
The potential global impact and cost-effectiveness of next-generation influenza vaccines: a modelling analysis
View ORCID ProfileLucy Goodfellow, View ORCID ProfileSimon R Procter, View ORCID ProfileMihaly Koltai, View ORCID ProfileNaomi R Waterlow, View ORCID ProfileJohnny A N Filipe, View ORCID ProfileCarlos K H Wong, View ORCID ProfileEdwin van Leeuwen, WHO Technical Advisory Group for the Full Value of Influenza Vaccines Assessment, View ORCID ProfileRosalind M Eggo, View ORCID ProfileMark Jit
doi: https://doi.org/10.1101/2024.09.19.24313950
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Lucy Goodfellow
1Department of Infectious Disease Epidemiology and Dynamics, London School of Hygiene and Tropical Medicine, London WC14 7HT, United Kingdom
Simon R Procter
1Department of Infectious Disease Epidemiology and Dynamics, London School of Hygiene and Tropical Medicine, London WC14 7HT, United Kingdom
Mihaly Koltai
1Department of Infectious Disease Epidemiology and Dynamics, London School of Hygiene and Tropical Medicine, London WC14 7HT, United Kingdom
Naomi R Waterlow
1Department of Infectious Disease Epidemiology and Dynamics, London School of Hygiene and Tropical Medicine, London WC14 7HT, United Kingdom
Johnny A N Filipe
1Department of Infectious Disease Epidemiology and Dynamics, London School of Hygiene and Tropical Medicine, London WC14 7HT, United Kingdom
Carlos K H Wong
1Department of Infectious Disease Epidemiology and Dynamics, London School of Hygiene and Tropical Medicine, London WC14 7HT, United Kingdom
22, Hong Kong SAR, China
Edwin van Leeuwen
1Department of Infectious Disease Epidemiology and Dynamics, London School of Hygiene and Tropical Medicine, London WC14 7HT, United Kingdom
3Modelling and Economics Unit and NIHR Health Protection Research Unit, UK Health Security Agency, London NW9 5EQ, United Kingdom
Rosalind M Eggo
1Department of Infectious Disease Epidemiology and Dynamics, London School of Hygiene and Tropical Medicine, London WC14 7HT, United Kingdom
Mark Jit
1Department of Infectious Disease Epidemiology and Dynamics, London School of Hygiene and Tropical Medicine, London WC14 7HT, United Kingdom
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Posted September 22, 2024.
The potential global impact and cost-effectiveness of next-generation influenza vaccines: a modelling analysis
Lucy Goodfellow, Simon R Procter, Mihaly Koltai, Naomi R Waterlow, Johnny A N Filipe, Carlos K H Wong, Edwin van Leeuwen, WHO Technical Advisory Group for the Full Value of Influenza Vaccines Assessment, Rosalind M Eggo, Mark Jit
medRxiv 2024.09.19.24313950; doi: https://doi.org/10.1101/2024.09.19.24313950
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Subject Area
Subject Areas
- Addiction Medicine (408)
- Allergy and Immunology (719)
- Anesthesia (214)
- Cardiovascular Medicine (3041)
- Dermatology (258)
- Emergency Medicine (456)
- Epidemiology (12962)
- Forensic Medicine (12)
- Gastroenterology (848)
- Genetic and Genomic Medicine (4772)
- Geriatric Medicine (440)
- Health Economics (747)
- Health Informatics (3028)
- Health Policy (1095)
- Hematology (405)
- HIV/AIDS (952)
- Medical Education (450)
- Medical Ethics (119)
- Nephrology (490)
- Neurology (4544)
- Nursing (242)
- Nutrition (671)
- Oncology (2364)
- Ophthalmology (666)
- Orthopedics (264)
- Otolaryngology (332)
- Pain Medicine (296)
- Palliative Medicine (86)
- Pathology (512)
- Pediatrics (1231)
- Primary Care Research (515)
- Public and Global Health (7135)
- Radiology and Imaging (1587)
- Respiratory Medicine (940)
- Rheumatology (456)
- Sports Medicine (396)
- Surgery (504)
- Toxicology (63)
- Transplantation (218)
- Urology (187)